ArticleAmerican journal of physiology. Heart and circulatory physiology2026
Optimized cardiac leukocyte isolation for flow cytometry enumeration and sorting.
Article in American journal of physiology. Heart and circulatory physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Accurate characterization of immune cell populations within the heart is critical for understanding inflammatory mechanisms that drive cardiac injury and repair. However, isolating viable leukocytes from cardiac tissue remains technically challenging due to the dense extracellular matrix, high collagen content, and susceptibility of immune subsets to enzymatic or mechanical stress. Here, we describe an optimized protocol for cardiac leukocyte isolation that maximizes cell yield, preserves viability, and maintains the integrity of surface markers for flow cytometric analysis and cell sorting. The method integrates controlled enzymatic digestion, gentle mechanical dissociation, and precise debris removal, thereby minimizing stromal contamination and reducing cellular activation artifacts. Using this approach, we demonstrate reproducible recovery of diverse immune populations, including neutrophils, monocytes, macrophages, and lymphocyte subsets from murine hearts. Furthermore, compatibility with high-dimensional flow cytometry and fluorescence-activated cell sorting enables robust downstream applications such as transcriptomic profiling and functional assays. This optimized isolation strategy provides a reliable and versatile tool for investigating the cardiac immune landscape, offering new opportunities to delineate the immunopathology of cardiovascular disease and to develop targeted immunomodulatory therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.